News

The monotherapy resulted in LDA by week 14 in both the 15 mg (45%) and 30 mg (53%) groups.

A commonly held belief has been debunked.

Rheumatology Network Writing Contest Official Rules

The aim of this study: to determine which patients need biologic therapy after starting methotrexate.

Among the culprits: sunlight, cigarettes, and oral contraceptives.

What underlies the disparity in life expectancy between men and women with SLE?

The goal: to find a treatment target that protects against damage accrual in the early stages of SLE.

Obese patients report higher disease activity, more depressive symptoms, and greater pain and fatigue.

Compared with conventional treatment, extracorporeal shock-wave therapy resulted in a significant decrease in finger ulcers.

MRI of the sacral spine may help determine which patients are in need of rheumatologic care.

The risk of pregnancy-related complications is further increased when juvenile arthritis persists into adulthood.

The frequency is significantly higher than in patients with chronic tension-type headaches and the symptoms are more severe.

New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.

The ACR/ARHP Annual Meeting provided a research update on surrounding issues and strategies for helping patients.

There’s a higher risk of total organ damage and end-stage renal disease in patients with SLE.

Up-to-date guidelines were developed to help improve patient outcomes.

If approved, this will be the first and only topical lotion that contains a unique combination formula.

Rates of prescription filling and treatment adherence are very low in patients with new diagnoses.

Rates of prescription filling and treatment adherence are very low in patients with new diagnoses.

The conditions often coexist, and a bidirectional association is suggested.

The incretin-insulin axis and incretin effect are disrupted in patients with RA.

This is the only fully human anti-TNF-α infused therapy approved for psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.

Previously approved for moderate-to-severe rheumatoid arthritis, golimumab received 2 new indications.

Patients who have RA and interstitial lung disease are at higher risk for dying than those who do not.

Continuing azathioprine and prednisolone past 2 years from diagnosis was superior to withholding them.

Exposure to cold environments has been linked to disease development, and new findings may help prevention.

This modality may enhance the diagnostic workup of patients with early arthralgia at risk for inflammatory arthritis.

Improvement in DAS28 scores was statistically significant in 26% of patients using adalimumab every 3 weeks compared to every 2 weeks.

An anti-inflammatory role might explain why the majority of patients are men.

Actemra/RoActemra has potential to change how GCA is treated.